By Colin KellaherRoyalty Pharma's board has raised the pharmaceutical investor's quarterly dividend by 5%, to 21 cents from 20 cents. The new payout, equal to 84 cents a year, represents an annual yield of about 3% based on Thursday's closing price of $28.04, up from 2.85%.

Source: Wall Street Journal January 19, 2024 19:20 UTC